Document Detail


Endoluminal treatment of peripheral chronic total occlusions using the crosser® recanalization catheter.
MedLine Citation:
PMID:  21891805     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE: Revascularization of lower extremity chronic total occlusions (CTOs) is technically challenging. The Crosser® recanalization catheter was designed to facilitate distal vessel intraluminal entry that is both rapid and safe. We present our experience with the Crosser device as primary therapy for peripheral CTOs.
METHODS: Subjects undergoing evaluation for arterial insufficiency at our institution between 2008-2010 who were noted to have a CTO in the lower extremity by duplex ultrasonography and who subsequently underwent Crosser recanalization were enrolled. Clinical characteristics, ankle-brachial indices, Rutherford-Becker symptom category, and angiographic CTO parameters were collected. Primary technical success was intraluminal delivery of the guidewire into the distal vessel solely by the Crosser device. Secondary technical success was assisted delivery using the Outback LTD® re-entry device. Safety endpoints were the occurrence of dissections, thromboembolism, and perforations related to the Crosser device. Statistical analysis was performed to find independent predictors for failure to achieve Crosser recanalization.
RESULTS: Fifty-six subjects with 73 CTOs were enrolled. The mean Crosser use time was 17.6 ± 12.7 minutes. The overall primary and secondary technical success rates for Crosser recanalization were 76.7% and 87.7%, respectively. Technical success was highest for CTOs located in the aorto-iliac (90.0%) and tibial (95.2%) arterial segments. There were no perforations related to the Crosser device. For successful cases, the mean ABI improved significantly from pre- to post-intervention (0.57 ± 0.13 to 0.89 ± 0.15, p < 0.001). The only predictors for failure were lesion length longer than 100 mm (p = 0.04) and calcification within 10 mm of the exit cap (p = 0.02).
CONCLUSION: The Crosser device is safe and shows excellent efficacy in facilitating guidewire distal lumen entry, especially for aorto-iliac and tibial occlusions. The technical success rate for the femoral and popliteal occlusions is comparable to those reported with other recanalization techniques.
Authors:
Cezar S Staniloae; Kanika P Mody; Sidharth S Yadav; Seol Young Han; Ravikiran Korabathina
Related Documents :
23346435 - Spontaneous rupture of an adrenal artery in pregnancy: a case report.
24619975 - Percutaneous catheter aspiration thrombectomy for the occluded stents of pulmonary arte...
23572475 - Computed tomography angiography spot sign does not predict case fatality in aneurysmal ...
23074575 - Single stage aortic valve replacement and splenectomy in a patient with severe aortic s...
10689735 - Normalization of orbital arterial blood flow in non-ischemic central retinal vein occlu...
1785265 - Doppler ultrasound assessment of endometrial pathology.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  23     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  359-62     Citation Subset:  IM    
Affiliation:
NYU Langone Medical Center, Cardiac and Vascular Institute, 550 First Avenue, New York, NY 10016 USA. cezar.staniloae@nyumc.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship of walking impairment and ankle-brachial index assessments with peripheral arterial tra...
Next Document:  New Drug-Eluting Stent Implantation for Recalcitrant In-Stent Restenosis Treated with Drug-Eluting S...